Retatrutide is a synthetic multi-agonist peptide studied in experimental models for its interaction with metabolic signaling pathways, including receptors associated with GLP-1, GIP, and glucagon. In preclinical and clinical research settings, retatrutide has been investigated for its potential effects on energy balance, glucose metabolism, and body-weight regulation through modulation of hormone-mediated metabolic signaling. Ongoing research examines how this peptide may influence pathways involved in appetite regulation, insulin sensitivity, and lipid metabolism in controlled experimental contexts.